Regulation of metastatic ability and drug resistance in pulmonary adenocarcinoma by matrix rigidity via activating c-Met and EGFR. [electronic resource]
- Biomaterials Aug 2015
- 141-50 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1878-5905
10.1016/j.biomaterials.2015.04.058 doi
Adenocarcinoma--diagnosis Adenocarcinoma of Lung Biomechanical Phenomena Cell Line, Tumor Collagen Type I--analysis Drug Resistance, Neoplasm Epithelial-Mesenchymal Transition--drug effects ErbB Receptors--analysis Erlotinib Hydrochloride--pharmacology Fibrosis Humans Indoles--pharmacology Integrins--analysis Lung--drug effects Lung Neoplasms--diagnosis Mechanotransduction, Cellular Prognosis Protein Kinase Inhibitors--pharmacology Proto-Oncogene Proteins c-met--analysis Sulfones--pharmacology